The Brexit Health Alliance is again warning that medicines supply in the UK is in danger of being disrupted if the issue of co-operative regulation is not addressed during Brexit negotiations. “Shared regulatory frameworks at EU level have been crucial in providing patients with faster access to treatments,” stress the authors of a new briefing […]
Post Type Archives: News
Syngenta opens research site in Ruiru, Kenya
Global agriculture firm Syngenta has opened a research site in Ruiru that will specialize in the multiplication of high quality cereals and vegetable seeds for the local and international markets. The new research site is part of the firm’s global push to empower farmers through innovation. Recurrent drought and poor seed quality are among the […]
Azelis companies win BASF Distributor of the Year Award
Ribelin Sales, an Azelis company, won two prestigious 2017 BASF Distributor of the Year Awards for outstanding sales of Colors & Effects branded pigments into the Coatings market as well as into Plastics. The awards were presented during the annual business review meetings at BASF pigment’s site in Charleston, SC. Ross Organic, another Azelis company, […]
Chemists create tinted windows that also generate electricity
A new discovery by Berkeley researchers may soon bring us windows that automatically tint on a sunny day to block the heat while also generating electricity. Peidong Yang, a professor of chemistry and faculty scientist at Berkeley Lab, and his colleagues have tweaked the chemical structure of perovskite — a versatile material that already rivals […]
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended seven medicines for approval, including one orphan medicine, at its January 2018 meeting. The CHMP recommended granting a marketing authorisation for Hemlibra.here (emicizumab), a first-in-class medicine to prevent bleeding episodes in patients with haemophilia A who have factor VIII inhibitors. This […]
Applied DNA to open Central DNA Testing Lab in India
Applied DNA Sciences has announced the establishment of a Central DNA Testing Laboratory in Ahmedabad, India providing full forensic authentication services. The laboratory will support global textile business in the Asia-Pacific region with expansion capability for other supply chains present in the region, such as fertilizer and pharmaceuticals. Officially opening on February 15, 2018, the […]
Nufarm creates Raiz program for pesticide distributors in Brazil
Nufarm has launched an initiative called Raiz Program in Brazil, to promote innovations, services and new technologies among the pesticide distributors in the region. Nufarm aims to widen its access to specific markets with this program. The program will be implemented first in the Northeastern region of the country. Sixty distributors were invited to participate […]
Applied DNA to develop molecular tracking for legal cannabis
Applied DNA Sciences has announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation, a leading full service cannabis consultancy with operations in the US, Canada, Australia, Europe and South America, for the integration of the Company’s SigNature molecular tagging and testing technology into TheraCann’s blockchain-based, seed-to-sale Enterprise Resource Platform […]
AbbVie to invest €113.6 million in sterile manufacturing
AbbVie plans to invest €113.6 million ($139 million) to expand its manufacturing facility in Sligo, Ireland to support its oncology pipeline. The investment is for new sterile manufacturing technology at the company’s Ballytivnan, Sligo site. The investment is expected to create approximately 100 new jobs over the course of three years in a variety of […]
Celgene to acquire Juno Therapeutics for $9 billion
Celgene has agreed to acquire Juno Therapeutics, a Seattle, Washington biopharmaceutical company developing cancer immunotherapies, for approximately $9 billion. Under the agreement, Celgene will pay $87 per share in cash, or a total of approximately $9 billion, net of cash and marketable securities acquired and Juno shares already owned by Celgene (approximately 9.7% of outstanding […]